THE EFFECT OF LONG-TERM TREATMENT WITH SULFONYLUREA DERIVATIVES ON PROTEIN METABOLISM IN DIABETES MELLITUS.
D000469:Alkaline Phosphatase / Q000097:blood*; D000596:Amino Acids; D001774:Blood Chemical Analysis; D001798:Blood Proteins; D003920:Diabetes Mellitus; D003927:Diet, Diabetic; D004586:Electrophoresis; D008111:Liver Function Tests; D008715:Methionine; D009584:Nitrogen; D011506:Proteins / Q000378:metabolism*; D000608:Renal Aminoacidurias; D013448:Sulfobromophthalein; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D014556:Urine
D000596:Amino Acids; D001798:Blood Proteins; D011506:Proteins; D013453:Sulfonylurea Compounds; D013448:Sulfobromophthalein; D014044:Tolbutamide; D008715:Methionine; D000469:Alkaline Phosphatase; D009584:Nitrogen
AMINO ACIDS; AMINOACIDURIA, RENAL; BLOOD ALKALINE PHOSPHATASE; BLOOD CHEMICAL ANALYSIS; BLOOD PROTEINS; DIABETES MELLITUS; DIABETIC DIET; ELECTROPHORESIS; LIVER FUNCTION TESTS; METHIONINE; NITROGEN; PROTEIN METABOLISM; SULFOBROMOPHTHALEIN; TOLBUTAMIDE; URINE